The need for greater involvement of regulatory agencies in assessing adverse drug reactions.
Sniderman
A D
AD
McGill University, Montreal, Que. allan.sniderman@muhc.mcgill.ca
D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards*; D001067:Appetite Depressants / Q000009:adverse effects; D004345:Drug Industry; D005277:Fenfluramine / Q000009:adverse effects; D006077:Government Agencies / Q000458:organization & administration*; D006349:Heart Valve Diseases / Q000139:chemically induced; D006801:Humans; D010645:Phentermine / Q000009:adverse effects; D018490:Serotonin Agents / Q000009:adverse effects
D001067:Appetite Depressants; D018490:Serotonin Agents; D005277:Fenfluramine; D010645:Phentermine